[go: up one dir, main page]

NZ803938A - Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders. - Google Patents

Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders.

Info

Publication number
NZ803938A
NZ803938A NZ803938A NZ80393818A NZ803938A NZ 803938 A NZ803938 A NZ 803938A NZ 803938 A NZ803938 A NZ 803938A NZ 80393818 A NZ80393818 A NZ 80393818A NZ 803938 A NZ803938 A NZ 803938A
Authority
NZ
New Zealand
Prior art keywords
diseases
treatment
pharmaceutical compositions
novel compounds
inflammatory disorders
Prior art date
Application number
NZ803938A
Inventor
Der Plas Steven Emiel Van
René Galien
David Amantini
Sébastien Martina
Pieter Claes
Ghjuvanni Coti
Denis Annoot
Ramos Miriam López
Reginald Brys
Oscar Mammoliti
Original Assignee
Galapagos Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1717260.2A external-priority patent/GB201717260D0/en
Application filed by Galapagos Nv filed Critical Galapagos Nv
Publication of NZ803938A publication Critical patent/NZ803938A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses compounds according to Formula I: Wherein R1, L1, R2, L2, R3, Cy, and the subscript n are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of allergic diseases, inflammatory diseases, metabolic diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IFN, IL12 and/or IL23 by administering the compound of the invention.
NZ803938A 2017-10-20 2018-10-11 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders. NZ803938A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1717260.2A GB201717260D0 (en) 2017-10-20 2017-10-20 Novel compounds and pharma ceutical compositions thereof for the treatment of inflammatory disorders
NZ76450518 2018-10-11

Publications (1)

Publication Number Publication Date
NZ803938A true NZ803938A (en) 2025-10-31

Family

ID=97493661

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ803938A NZ803938A (en) 2017-10-20 2018-10-11 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders.

Country Status (1)

Country Link
NZ (1) NZ803938A (en)

Similar Documents

Publication Publication Date Title
PH12020550230A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
PH12020550725A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
PH12020552160A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
MX355653B (en) NOVEL COMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE and INFLAMMATORY DISEASES.
PH12017501061A1 (en) 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
MX2021013803A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases.
PH12017501921A1 (en) Novel compounds
TW201613873A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
PH12019502853A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
PH12018501849A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
PH12021552375A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
PH12016501977A1 (en) 2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES
PH12014502615B1 (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
MY178053A (en) Carboxylic acid compounds
PH12021552377A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MX2017013099A (en) Methods for the treatment of inflammatory disorders.
PH12019501853A1 (en) Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
PH12021552376A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
PH12021552680A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases
MX2020001199A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases.
MX2019014272A (en) Ergoline derivatives for use in medicine.
PH12021552032A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
NZ803938A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders.
UY37032A (en) HETEROARILBENZIMIDAZOL COMPOUNDS